New repurposing strategy identifies saracatinib as potential cardiovascular immunotherapy candidate
June 15, 2023
In recent work, researchers from Mount Sinai School of Medicine applied a drug repurposing approach to identify candidates that could target inflammation in atherosclerosis.
